Pharmaceutical Executive - Pharmaceutical news and analysis. Pharma management, sales, marketing & finance

ADVERTISEMENT

Previous Story Play / Pause Next Story
New & Noteworthy
The Human Microbiome — Our Body's Secret Weapon
New research on the role of microbes in fighting disease is transforming the way medicine views bacteria, writes Lee Jones.
The Gate Keeper: Dr. David Haslam, Chair of NICE, UK
NICE's David Haslam discusses the UK drug watchdog's new challenge in meeting expectations around what quantitative calculations of value mean to patient access today.
Big Data Meets Personalized Medicine
Data analytic strategies can help companies capitalise on personalised medicine, writes Jill E. Sackman and Michael Kuchenreuther.

Latest Pharm Exec Videos

Events
Medicaid and Government Pricing Congress
June 3, 2015 - June 5, 2015
Lake Buena Vista, FL USA

13th Annual Product Complaints Congress for Life Sciences
June 23, 2015 - June 25, 2015
Washington, DC USA

PAAS 2015 – Patient Adherence and Access Summit
June 23, 2015 - June 24, 2015
Philadelphia, PA USA

Contracts, Chargebacks and Rebates Congress
June 24, 2015 - June 25, 2015
Philadelphia, PA USA

Speed to Therapy
August 11, 2015 - August 12, 2015
Philadelphia, PA USA

Pharma Feels Impact of US Tax Inversion Legislation
US Healthcare Reform: A Pharm Exec Digest Special
The Shrinking CMO Industry
The Baltic States: A Location for Your Next Clinical Trial
New CDER Super Office to Promote Drug Quality
Pulling Back the Curtains on Obamacare Rx Usage
From the Editor William LooneyYouthquake: How the Millennials are Shaping US Healthcare
Europe ReflectorEruptions on the European Drug-Pricing Horizon
Training Stan BernardGain Competitive Advantage: Think Like a Navy SEAL
Biosimilars Jill WechslerGaps in Global Standards Threaten Biosimilar Development
 More
Survey
Which of these concerns you the most with regard to your firm's growth prospects?
Slow or negative growth in developed economies
Slowdown in high-growth markets
Slow or negative growth in developed economies
56%
Slowdown in high-growth markets
44%
View Results
PHARM EXEC GLOBAL DIGEST
Pharmaceutical Executive Digest EuropeTo read the latest issue of Pharm Exec Global Digest
Click here. Click here to receive the Digest into your inbox every month.
Click here